Global Human Papillomavirus (HPV) Associated Cancer Pipeline Guide, H1 2020: Therapeutics, Drugs, Products, Players, Projects
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: PR Newswire
DUBLIN, April 22, 2020 /PRNewswire/ -- The "Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.Human Papillomavirus Associated Cancer - Pipeline Review, H1 2020 provides comprehensive information on the therapeutics under development for Human Papillomavirus Associated Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Human Papillomavirus Associated Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Human Papillomavirus (HPV) Associated Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the mole
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026GlobeNewswire
- 2 Healthcare Stocks to Buy and 1 to Approach With Caution [Yahoo! Finance]Yahoo! Finance
- BioNTech (BNTX) had its "buy" rating reaffirmed by Berenberg Bank.MarketBeat
- BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial CancerGlobeNewswire
- BioNTech (BNTX) had its price target raised by Morgan Stanley from $125.00 to $126.00. They now have an "overweight" rating on the stock.MarketBeat
BNTX
Earnings
- 3/10/26 - Beat
BNTX
Sec Filings
- 4/13/26 - Form 3/A
- 4/13/26 - Form 6-K
- 4/2/26 - Form 6-K
- BNTX's page on the SEC website